The Cancer Omics Atlas: an integrative resource for cancer omics annotations
暂无分享,去创建一个
[1] Jamie R. Kutasovic,et al. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer , 2013, Virchows Archiv.
[2] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[3] M. Todaro,et al. By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy , 2014, Oncotarget.
[4] Martin L. Miller,et al. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.
[5] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[6] Y. Shentu,et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial , 2016, The Lancet.
[7] M. Valsecchi. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.
[8] Pornpimol Charoentong,et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.
[9] Akira Nakagawara,et al. Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation* , 2004, Journal of Biological Chemistry.
[10] Xiaoli Liu,et al. Low expression of dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein in lung cancer and significant correlations with brain metastasis and natural killer cells , 2015, Molecular and Cellular Biochemistry.
[11] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[12] Karin Breuer,et al. InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..
[13] Xue Han,et al. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. , 2015, The Journal of clinical investigation.
[14] Richard Simon,et al. Identification of potential synthetic lethal genes to p53 using a computational biology approach , 2013, BMC Medical Genomics.
[15] J. Chen,et al. Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential , 2015, Cellular Physiology and Biochemistry.
[16] Xiaosheng Wang,et al. Transcriptional landscape of human cancers , 2017, Oncotarget.
[17] Hejun Zhang,et al. Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. , 2016, Cancer genetics.
[18] F. Fuller-Pace,et al. p53-dependent repression of polo-like kinase-1 (PLK1) , 2010, Cell cycle.
[19] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[20] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[22] Xiaosheng Wang,et al. PLK1, A Potential Target for Cancer Therapy , 2016, Translational oncology.
[23] A. Xia,et al. High frequency of the IVS2-2A>G DNA sequence variation in SLC26A5, encoding the cochlear motor protein prestin, precludes its involvement in hereditary hearing loss , 2005, BMC Medical Genetics.
[24] Jun Li,et al. TCPA: a resource for cancer functional proteomics data , 2013, Nature Methods.
[25] J. Sosman,et al. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma , 2016, Cell.
[26] X. Qiu,et al. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma , 2016, Journal of experimental & clinical cancer research : CR.
[27] Jana Jeschke,et al. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data , 2015, BMC Genomics.